Advocates Defend Animal Testing Amid Push for Alternatives

Discussions surrounding the use of animal testing in medical research have intensified following a recent editorial that argued for a shift away from this practice. The editorial published on November 23, 2023, in *The Guardian* suggested that the reliance on animals for research should be significantly reduced. In response, prominent scientists have voiced their support for animal research, emphasizing its continued importance in achieving medical advancements.

Dr. Robin Lovell-Badge, a principal group leader at the Francis Crick Institute and president of the Institute of Animal Technologists, highlighted the complexity of scientific discovery. He acknowledged the necessity of developing and validating alternative methods to animal testing, but he warned that these alternatives are often more applicable to regulatory testing than to fundamental research. Lovell-Badge pointed out that while all UK scientists working with animals adhere to the principles of the 3Rs—replacement, reduction, and refinement—complete abandonment of animal research is not yet feasible.

Advancements in technology, such as the ability to gather extensive data on gene activity, have indeed transformed the scientific landscape. However, Lovell-Badge cautioned that these developments often yield only correlative data. Establishing causation still requires controlled testing, a process that can only currently be achieved through animal studies. He expressed concern that pushing for a rapid transition to alternative methods might hinder the discovery of new treatments for both human and animal health.

In addition, Lovell-Badge emphasized the importance of skilled animal technologists in maintaining high standards of animal care. He noted that losing these trained professionals could diminish the UK’s competitiveness in biomedical research and negatively impact animal welfare.

Prof. Emma Robinson, a professor of psychopharmacology at the University of Bristol, further elucidated the limitations of current alternatives. She pointed out that most studies employing New Approach Methodologies (NAMs) still rely on animal-derived products. For instance, while some cell cultures can be derived from human stem cells, the essential growth matrices and media often remain animal-based.

Robinson highlighted that substances like matrigel, obtained from mouse tumors, are crucial for the growth of organoids and organs-on-a-chip. These technologies, while promising, are currently constrained by the need for animal-derived materials. She stressed the necessity of ongoing animal research to gain a comprehensive understanding of complex biological processes, particularly in diseases that involve developmental changes, aging, and intricate interactions between biology and the environment.

Both Lovell-Badge and Robinson advocate for increased investment in NAMs, particularly for straightforward assays related to toxicity and pharmacokinetics. They argue that adjusting regulations to allow for the use of these methodologies, while still ensuring safety, could facilitate their adoption and ultimately reduce reliance on animal testing.

In summary, while the push for alternatives to animal testing is welcomed and necessary, experts assert that animal research remains a critical component of medical science. Without it, the journey toward significant medical breakthroughs could stall, impacting both human and animal health in the long run.